21 CFR Part 11 establishes FDA requirements for electronic records and electronic signatures, critical for pharmaceutical analytical instruments.
Key Requirements
Electronic Records
Systems must ensure:
- Records are accurate and complete
- Records cannot be altered without detection
- Records are readily available for review
Electronic Signatures
Requirements include:
- Unique to individual users
- Cannot be reused or reassigned
- Linked to corresponding records
System Controls
Access Control
- Unique user IDs and passwords
- Role-based access levels
- Password policies and expiration
- Account lockout after failed attempts
Audit Trails
Systems must maintain:
- Date and time stamps
- User identification
- Actions performed
- Before and after values for changes
Data Integrity
Ensure:
- No unauthorized modifications
- Complete record retention
- Backup and recovery procedures
Instrument-Specific Considerations
Dissolution Testers
- Temperature and speed parameter logging
- Test result integrity
- Method storage and retrieval
Hardness Testers
- Force measurement records
- Statistical calculation verification
- Data export security
Disintegration Testers
- Timing records
- Temperature monitoring data
- Pass/fail documentation
Implementation Steps
- Gap Assessment: Evaluate current systems against requirements
- System Selection: Choose compliant equipment
- Validation: Demonstrate system meets requirements
- Training: Ensure users understand requirements
- Ongoing Monitoring: Maintain compliance over time
Documentation
Maintain:
- Validation protocols and reports
- User training records
- SOP documentation
- Audit trail reports